Dilpacimab

• Target :

  VEGFR|||Gamma-secretase

• Related Pathways :

  Angiogenesis|||Stem Cells|||Neuroscience|||Proteases/Proteasome|||Tyrosine Kinase/Adaptors

• Purity :

  0.977

• Bioactivity :

  Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin that simultaneously targets the delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) signaling pathways. Dilpacimab has significant potential in cancer research due to its dual targeting of tumor angiogenesis and Notch signaling.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1791420-09-1